)
Catalyst Pharmaceuticals (CPRX) investor relations material
Catalyst Pharmaceuticals EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting commenced with instructions for participation and a welcome from the board chair.
Agenda included voting on three specific proposals as outlined in the proxy statement.
Board and executive committee updates
Introductions of all board members and executive officers were made at the start of the meeting.
Corporate governance
The chairperson was authorized to preside and set meeting procedures per the company's bylaws.
The record date for voting was set as June 3, 2026, and all required notices and proxy materials were confirmed as mailed.
Inspector of Election was appointed and sworn in, with responsibilities for vote canvassing and reporting.
Quorum was confirmed with a majority of shares represented.
- Strong growth in rare disease portfolio, robust cash, and strategic expansion plans for 2026.CPRX
Barclays 28th Annual Global Healthcare Conference8 Jul 2026 - Record revenue and net income growth in 2024, with strong 2025 outlook and robust cash position.CPRX
Q4 20248 Jul 2026 - Q1 2025 revenue surged 43.6% to $141.4M, led by FIRDAPSE and AGAMREE growth.CPRX
Q1 20258 Jul 2026 - DMD therapies advance with novel delivery, regulatory support, and key data expected in Q1.CPRX
Citi's 2024 Global Healthcare Conference8 Jul 2026 - Q3 revenue up 25.3% year-over-year, with raised guidance and strong cash reserves.CPRX
Q3 20248 Jul 2026 - Shareholders will vote on a merger with Angelini Pharma amid legal scrutiny and executive retention plans.CPRX
Proxy filing30 Jun 2026 - Shareholders to vote on $31.50/share cash merger with Angelini Pharma, board recommends approval.CPRX
Proxy filing8 Jun 2026 - Shareholders to vote on a $31.50/share cash merger with Angelini Pharma, unanimously backed by the board.CPRX
Proxy filing28 May 2026 - Merger with Angelini Pharma announced; Q1 2026 revenues up 28.2% to $149.4 million.CPRX
Proxy filing12 May 2026
Next Catalyst Pharmaceuticals earnings date
Next Catalyst Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)